Scholars Central

PerspectivePublished 30 Sep 2024

The Role of mRNA Technology in the Future of Vaccine Research

Authors: Alex Mayra

School of Medicine, Lutheran University of Brazil, Brazil

Immunology: Current Research

Volume 8 · Issue 5 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

mRNA technology has revolutionized vaccine development, offering rapid production and robust immune responses. The recent success of mRNA vaccines against COVID-19 has highlighted the potential of this platform in combating infectious diseases. Unlike traditional vaccines, which rely on inactivated pathogens or proteins, mRNA vaccines introduce messenger RNA into cells, instructing them to produce a target antigen that stimulates the immune system. This technology allows for faster vaccine development, flexibility in addressing mutating pathogens, and the ability to target diseases that have been difficult to address using conventional approaches. Furthermore, mRNA vaccines have shown promise in providing long-term immunity and can be tailored to a wide range of infectious diseases. This paper explores the advancements in mRNA vaccine research, challenges in distribution and acceptance, and the future potential of mRNA technology in vaccine development.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Immunology: Current Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImmunology: Current Research
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Alex Mayra”